[The new aspects of treatment of severe sepsis and septic shock]

Medicina (Kaunas). 2006;42(4):265-72.
[Article in Lithuanian]

Abstract

The mortality rate of infection-induced organ dysfunction or hypoperfusion abnormalities due to severe sepsis and septic shock remains unacceptably high. The adequacy and speed of treatment administered in the first hours after syndrome develops influence outcome. Initial resuscitation, appropriate antimicrobial treatment, selection of optimal control methods, properties of fluid therapy, use of vasopressors and inotropic therapy, proper corticosteroid administration, value of the use of recombinant human activated protein C, and glucose control are the most important points newly evaluated for severe and septic shock management.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • APACHE
  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Blood Glucose / analysis
  • Blood Transfusion
  • Cardiotonic Agents / administration & dosage
  • Cardiotonic Agents / therapeutic use
  • Fluid Therapy
  • Humans
  • Meta-Analysis as Topic
  • Protein C / therapeutic use
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins / therapeutic use
  • Sepsis / diagnosis
  • Sepsis / drug therapy
  • Sepsis / mortality
  • Sepsis / physiopathology
  • Sepsis / therapy*
  • Shock, Septic / diagnosis
  • Shock, Septic / drug therapy
  • Shock, Septic / mortality
  • Shock, Septic / physiopathology
  • Shock, Septic / therapy*
  • Time Factors
  • Vasoconstrictor Agents / administration & dosage
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Blood Glucose
  • Cardiotonic Agents
  • Protein C
  • Recombinant Proteins
  • Vasoconstrictor Agents
  • drotrecogin alfa activated